InvestSMART

Oneview Healthcare Plc (ASX:ONE)

ALERT: Price-sensitive ASX Announcement for ONE
Current share price for ONE : $0.170 -0.21 (-55.26%)+
Announcement
Release
15 Jan 2026 4:42PM
Price at Release
$0.380
Full Release
download
Summary
Oneview Healthcare Plc released its Appendix 4C Quarterly Cash Flow Report for the fourth quarter of 2025, ending 31 December 2025. The report highlights a decrease in cash balance to €4.6 million (A$8.1 million), and a net operating cash outflow of €1.4 million (A$2.5 million). The company experienced a significant increase in customer receipts, reaching €3.5 million (A$6.3 million) compared to the previous year, attributed to higher revenue and the timing of receipts. Operational activities included the signing of a new contract with Peterson Health in Texas and expansion into a major U.S. health system through a strategic partnership with Baxter. The company deployed over 500 endpoints in Q4 2025, with total live endpoints reaching 14,880. Despite some deployment delays, Oneview is positioned strongly for 2026, bolstered by commercial momentum and improved deployment efficiency.
Key Points
  • Oneview’s cash balance at 31 December 2025 was €4.6 million.
  • Net operating cash outflow of €1.4 million during the quarter.
  • Receipts from customers increased to €3.5 million due to higher revenue.
  • New customer contract with Peterson Health, Texas.
  • Strategic partnership with Baxter expands access to a major U.S. health system.
  • Over 500 endpoints deployed in Q4 2025, total live endpoints at 14,880.
  • Strong positioning for 2026 with enhanced commercial traction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.